Skip to main content
Top

Clinical & Experimental Metastasis

Issue 5/2009

Content (10 Articles)

Research Paper

Pulmonary lymphangitic sarcomatosis and a review of the literature

Tanseli Gonlugur, Feride Sapmaz, Ozgur Katrancioglu, Ugur Gonlugur, Sahende Elagoz

Research Paper

Noninvasive imaging of the functional effects of anti-VEGF therapy on tumor cell extravasation and regional blood volume in an experimental brain metastasis model

Juan JuanYin, Kirsten Tracy, Luhua Zhang, Jeeva Munasinghe, Erik Shapiro, Alan Koretsky, Kathleen Kelly

Research Paper

Dietary stearate reduces human breast cancer metastasis burden in athymic nude mice

Lynda M. Evans, Eric C. Toline, Renee Desmond, Gene P. Siegal, Arig Ibrahim Hashim, Robert W. Hardy

Open Access Research Paper

Inhibition of cyclooxygenase-2 suppresses the invasiveness of oral squamous cell carcinoma cell lines via down-regulation of matrix metalloproteinase-2 production and activation

Yuji Kurihara, Masashi Hatori, Yuriko Ando, Daisuke Ito, Takahiko Toyoshima, Makoto Tanaka, Satoru Shintani

Research Paper

Invasive prostate cancer cells are tumor initiating cells that have a stem cell-like genomic signature

George J. Klarmann, Elaine M. Hurt, Lesley A. Mathews, Xiaohu Zhang, Maria A. Duhagon, Tashan Mistree, Suneetha B. Thomas, William L. Farrar

Research Paper

NK4, an HGF antagonist, prevents hematogenous pulmonary metastasis by inhibiting adhesion of CT26 cells to endothelial cells

Takeshi Kubota, Hiroaki Taiyoh, Atsushi Matsumura, Yasutoshi Murayama, Daisuke Ichikawa, Kazuma Okamoto, Hitoshi Fujiwara, Hisashi Ikoma, Masayoshi Nakanishi, Shojiro Kikuchi, Chouhei Sakakura, Toshiya Ochiai, Yukihito Kokuba, Hiroki Taniguchi, Teruhisa Sonoyama, Kunio Matsumoto, Toshikazu Nakamura, Eigo Otsuji

Research Paper

Transient RNA silencing of tissue factor pathway inhibitor-2 modulates lung cancer cell invasion

Sophie Iochmann, Claire Bléchet, Valérie Chabot, Annabelle Saulnier, Aniça Amini, Guillaume Gaud, Yves Gruel, Pascale Reverdiau

Original Paper

Des-γ-carboxy prothrombin stimulates human vascular endothelial cell growth and migration

Su-Bo Wang, Yan-Na Cheng, Shu-Xiang Cui, Julia Li Zhong, S. G. Ward, Li-Rui Sun, Ming-Hui Chen, Norihiro Kokudo, Wei Tang, Xian-Jun Qu

Research Paper

Radiological changes following second-line zoledronic acid treatment in breast cancer patients with bone metastases

E. Amir, C. Whyne, O. C. Freedman, M. Fralick, R. Kumar, M. Hardisty, M. Clemons

Open Access Research Paper

Osteoblast-induced EGFR/ERBB2 signaling in androgen-sensitive prostate carcinoma cells characterized by multiplex kinase activity profiling

Åse Bratland, Piet J. Boender, Hanne K. Høifødt, Ingrid H. G. Østensen, Rob Ruijtenbeek, Meng-yu Wang, Jens P. Berg, Wolfgang Lilleby, Øystein Fodstad, Anne Hansen Ree

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine